Atrial Fibrillation Drug Forecast to 2023

1
EpiCast Report Atrial Fibrillation Epidemiology
Forecast to 2023 By RnRMarketResearch

• Browse more reports on Pharmaceuticals at
  http//www.rnrmarketresearch.com/reports/life-scie
  nces/pharmaceuticals

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
2
Atrial Fibrillation Epidemiology Forecast to 2023

• Atrial fibrillation (AF) is a disorder of the
  hearts electrical system. The condition is
  characterized by an irregular heart rhythm that
  is either too fast or too slow. During AF, the
  two upper chambers of the heart (atria) beat out
  of coordination with the two lower chambers
  (ventricles) due to disorganized electrical
  signals, resulting in poor blood supply to the
  lungs and the rest of the body. The symptoms of
  AF typically include heart palpitations,
  irregular and fast heartbeat, chest discomfort,
  shortness of breath, dizziness, and weakness.
  However, individuals with AF may be asymptomatic
  and not even know that they have the condition
  until it is identified through an
  electrocardiogram (EKG or ECG) test.
• Complete report available at http//www.rnrmarketr
  esearch.com/epicast-report-atrial-fibrillation-epi
  demiology-forecast-to-2023-market-report.html .

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
3
Atrial Fibrillation Epidemiology Forecast to 2023
AF is one of the most common cardiovascular
diseases among the elderly, worldwide. Although
AF affects people of all ages, the condition is
rare in individuals younger than 40 years of age.
The risk for AF increases rapidly with age and is
more common in men than women. Globally, the
prevalence of AF varies widely, depending on the
country and the study, ranging from 0.1-1.6 in
Asia (0.1 in India, 1.6 in Japan), 0.95-3.9 in
North America (0.95 in the US, 3.9 in Canada),
1.28-2.1 in Europe (1.28 in the UK, 2.1 in
Germany), and 4.0 in Australia. (This is a
premium report priced at US3995 for a single
user License.)
http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
4
Atrial Fibrillation Epidemiology Forecast to 2023

• Scope
• The Atrial Fibrillation (AF) EpiCast Report
  provides an overview of the risk factors,
  comorbidities, and the global and historical
  trends for AF in the eight major markets (8MM)
  (US, France, Germany, Italy, Spain, UK, Japan,
  and Canada). It includes a 10-year
  epidemiological forecast for the diagnosed
  prevalent cases of AF segmented by sex, age (in
  five-year age groups, beginning at 40 years and
  ending at 85 years), and clinical subtypes
  (paroxysmal, persistent, and permanent AF) in
  these markets.
• The AF epidemiology report is written and
  developed by Mastersand PhD-level
  epidemiologists.
• The EpiCast Report is in-depth, high quality,
  transparent and market-driven, providing expert
  analysis of disease trends in the 8MM.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
5
Atrial Fibrillation Epidemiology Forecast to 2023

• Reasons to Buy
• Develop business strategies by understanding the
  trends shaping and driving the global AF market.
• Quantify patient populations in the global AF
  market to improve product design, pricing, and
  launch plans.
• Organize sales and marketing efforts by
  identifying the sex and age groups that present
  the best opportunities for AF therapeutics in
  each of the markets covered.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
6
Atrial Fibrillation Epidemiology Forecast to 2023

• For more details contact Mr. Ritesh Tiwari
  sales_at_rnrmarketresearch.com / 18883915441

RnRMarkertResearch RnRMarketResearch.com, an
online repository of market  research reports,
offers in-depth analysis of over 5000 market
segments. RnR Market Research library has
syndicated reports by leading market research 
publishers across the globe.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441